IHTI.US Integrative Health Technologies Inc
- Market cap
- USD 1.63K
- P/E
- -
- P/B
- 0.04x
- ROE
- 0.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2009.
Is IHTI.US undervalued?
Graham numberThe Graham number of Integrative Health Technologies Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Integrative Health Technologies Inc fundamental analysis
No fundamental analysis for Integrative Health Technologies Inc yet.
Integrative Health Technologies Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Integrative Health Technologies Inc
Integrative Health Technologies, Inc. provides fee-based clinical trials, research and development, and consulting and testing services to the healthcare and nutritional industries. The company maintains a database that contains more than 30,000 tests and dates back more than 20 years which tracks the footprints of diseases. It also operates mobile and stationary dual energy x-ray absorptiometry (DEXA) body composition scanning units for measuring total body and regional bon…
Full company profileIntegrative Health Technologies Inc financial statements
Integrative Health Technologies Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | - | - | 0.00 | 0.00 | 14.9K | 565K | 431K | 447K |
| Gross Profit | - | - | 0.00 | 0.00 | 14.9K | 103K | 75.3K | 77.6K |
| Operating Income | -18.0K | 539K | -2.83M | -55.2K | -37.2K | 21.2K | 26.5K | 38.7K |
| EBITDA | -16.7K | -456K | -2.82M | -55.2K | -37.2K | - | - | 38.7K |
| Net Income | -18.0K | -648K | -2.54M | -55.2K | -37.2K | 21.2K | 26.5K | 38.7K |
| EPS | -0.25 | -9.15 | -4.89 | -0.07 | -0.05 | - | - | - |
| Balance Sheet | ||||||||
| Total Assets | 1.61K | 164K | 1.22M | 1.34M | 9.66M | 7.14M | 7.75M | 8.25M |
| Total Liabilities | 31.8K | 610K | 1.26M | 959K | 435K | 248K | 298K | 298K |
| Shareholders' Equity | -30.2K | -446K | -45.6K | 381K | 9.22M | 6.90M | 7.45M | 7.95M |
| Cash & Short-term Investments | - | - | - | 1.34M | 8.05M | 7.14K | 22.2K | 27.0K |
| Total Debt | - | 250K | 670K | 614K | 122K | - | - | - |
| Cash Flow | ||||||||
| Operating Cash Flow | -3.00K | -99.6K | 648K | -1.30M | -65.0K | - | - | - |
| Capital Expenditure | 0.00 | 0.00 | 780.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -3.00K | -99.6K | 647K | -1.30M | -65.0K | - | - | - |
| Ratios | ||||||||
| ROE | - | - | - | -14.5% | -0.4% | 0.3% | 0.4% | 0.5% |
| ROA | -1,117.9% | -395.1% | -208.5% | -4.1% | -0.4% | 0.3% | 0.3% | 0.5% |
| Net Profit Margin | - | - | - | - | -250.0% | 3.8% | 6.1% | 8.6% |
| Debt to Equity | - | - | - | 1.61x | 0.01x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Integrative Health Technologies Inc dividends
Integrative Health Technologies Inc has not paid dividends in the last 8 fiscal years.
Last stock split: 1:200 on Mar 26, 2007.
Who owns Integrative Health Technologies Inc
Ownership data of Integrative Health Technologies Inc is not available yet.
Integrative Health Technologies Inc company profile
- Company name
- Integrative Health Technologies Inc
- Ticker
- IHTI.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Fiscal year end
- December
- Address
- 5170 Broadway, San Antonio, TX, United States, 78209
- Phone
- 210-824-4200
- Website
- ihtresearch.com
About Integrative Health Technologies Inc
Integrative Health Technologies, Inc. provides fee-based clinical trials, research and development, and consulting and testing services to the healthcare and nutritional industries. The company maintains a database that contains more than 30,000 tests and dates back more than 20 years which tracks the footprints of diseases. It also operates mobile and stationary dual energy x-ray absorptiometry (DEXA) body composition scanning units for measuring total body and regional bone densities, and body fat and lean mass. In addition, the company provides blood chemistry testing report that provides 43 chemistries, including HDL, LDL, C-reactive protein, thyroid, electrolytes, red and white blood cell counts, and glucose, etc. Integrative Health Technologies, Inc. was founded in 1999 and is based in San Antonio, Texas.
Integrative Health Technologies Inc management
2- Mr. Gilbert R. Kaats Ph.D.Chairman, CEO, President, CFO & Member of Scientific Advisory Board
- Ms. Shirlie KaatsSecretary & Director